p53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors

被引:36
作者
Epstein, CB [1 ]
Attiyeh, EF [1 ]
Hobson, DA [1 ]
Silver, AL [1 ]
Broach, JR [1 ]
Levine, AJ [1 ]
机构
[1] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
关键词
p53; yeast; mutations; cancer;
D O I
10.1038/sj.onc.1201734
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is a transcriptional activator that plays a key role in the integration of signals inducing cell division arrest and programed cell death, Moreover, p53 is a tumor suppressor gene, mutations of which are the most commonly detected mutations in diverse malignancies. In order to better understand the significance of p53 mutations to human cancer, me isolated mutant alleles of p53 that had lost transcription factor activity in yeast. These mutant alleles mere evaluated for their precise changes, their activity against three different p53 responsive enhancers and their ability to act in a transdominant fashion to the wild type allele, While many of the mutations isolated in yeast resembled those found in human tumors, consistent with the importance of transcription factor activity for p53 in mammalian cells, the mutational spectrum obtained was dependent upon the p53 enhancer employed for the selection. Some mutations specifically inactivated p53 in yeast for a single enhancer element. Virtually all missense mutations tested had a dominant inhibitory effect on wild type p53 in yeast, Since some of these transdominant mutations are virtually unknown in human tumors me conclude that transdominance, per se, fails to predict which mutations occur frequently in cancer.
引用
收藏
页码:2115 / 2122
页数:8
相关论文
共 53 条
  • [1] Ausubel FM., 1994, Curr. Protoc. Mol. Biol
  • [2] Dominant-negative p53 mutations selected in yeast hit cancer hot spots
    Brachmann, RK
    Vidal, M
    Boeke, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4091 - 4095
  • [3] CHEN JY, 1993, ONCOGENE, V8, P2159
  • [4] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [5] TRANSCRIPTIONAL ACTIVATION BY P53 CORRELATES WITH SUPPRESSION OF GROWTH BUT NOT TRANSFORMATION
    CROOK, T
    MARSTON, NJ
    SARA, EA
    VOUSDEN, KH
    [J]. CELL, 1994, 79 (05) : 817 - 827
  • [6] GAIN OF FUNCTION MUTATIONS IN P53
    DITTMER, D
    PATI, S
    ZAMBETTI, G
    CHU, S
    TERESKY, AK
    MOORE, M
    FINLAY, C
    LEVINE, AJ
    [J]. NATURE GENETICS, 1993, 4 (01) : 42 - 46
  • [7] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    [J]. NATURE, 1992, 358 (6381) : 83 - 86
  • [10] A genetic approach to mapping the p53 binding site in the MDM2 protein
    Freedman, DA
    Epstein, CB
    Roth, JC
    Levine, AJ
    [J]. MOLECULAR MEDICINE, 1997, 3 (04) : 248 - 259